Product Pipeline

The company has prioritised development for unmet need in idiopathic pulmonary fibrosis (IPF) and other pulmonary fibroses.

The extensive evidence implicating TGF-β in asthma and chronic obstructive pulmonary disease (COPD) supports separate developments with optimised selectivity and formulation.